Clinical Trial Update: Mesenchymal Stem Cells in Central Nervous System injury2017 [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for mesenchymal stem cells in central nervous system injury across Phase 1 and Phase 2, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Injury

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Central Nervous System Injury | Phase 1, Phase 2 | Status: UNKNOWN